Nordic Stem Cell Clinic ApS: Financial statements 2025
CVR: 44048434
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Nordic Stem Cell Clinic ApS (CVR 44048434) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -68,935 and a net result of DKK -4,310,487 compared with DKK -264,713 the year before. Equity in the 2025 report amounted to DKK -3,471,944.
- Gross Profit
- DKK -68,935
- Profit/Loss
- DKK -4,310,487
- Equity
- DKK -3,471,944
- Total Assets
- DKK 127,096
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -69K | -4.3M | -3.5M | 0 |
| 2024 | - | -265K | -265K | 839K | - |
Official annual report
How creditworthy is Nordic Stem Cell Clinic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Nordic Stem Cell Clinic ApS has published its annual report for 2024. Gross profit came to DKK -264,713, and the net result was DKK -264,713.
About Nordic Stem Cell Clinic ApS
Nordic Stem Cell Clinic ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Blue Cell Clinics ApS. The management consists of Søren Paludan Sheikh. The company is owned by ANDRÉ ROGACZEWSKI HOLDING II ApS, SPSheikh Holding ApS and Ulveman Invest ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -68,935 and a net result of DKK -4,310,487 compared with DKK -264,713 the year before. Equity in the 2025 report amounted to DKK -3,471,944.
